WuXi Biologics (Cayman) Inc
HKEX:2269

Watchlist Manager
WuXi Biologics (Cayman) Inc Logo
WuXi Biologics (Cayman) Inc
HKEX:2269
Watchlist
Price: 24.95 HKD -3.11% Market Closed
Market Cap: 102.5B HKD

Wall Street
Price Targets

Price Targets Summary
WuXi Biologics (Cayman) Inc

Wall Street analysts forecast WuXi Biologics (Cayman) Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for WuXi Biologics (Cayman) Inc is 29.03 HKD with a low forecast of 10.1 HKD and a high forecast of 47.25 HKD.

Lowest
Price Target
10.1 HKD
60% Downside
Average
Price Target
29.03 HKD
16% Upside
Highest
Price Target
47.25 HKD
89% Upside
WuXi Biologics (Cayman) Inc Competitors:
Price Targets
4880
CellSource Co Ltd
28% Upside
SFZN
Siegfried Holding AG
22% Upside
SHC
Sotera Health Co
26% Upside
DHR
Danaher Corp
31% Upside
OABI
OmniAb Inc
529% Upside
BANB
Bachem Holding AG
39% Upside
FLB
Fluidigm Corp
137% Upside
GENO
Genovis AB
47% Upside

Revenue
Forecast

Revenue Estimate
WuXi Biologics (Cayman) Inc

For the last 8 years the compound annual growth rate for WuXi Biologics (Cayman) Inc's revenue is 44%. The projected CAGR for the next 3 years is 15%.

44%
Past Growth
15%
Estimated Growth
Estimates Accuracy
1%
Average Beat

Operating Income
Forecast

Operating Income Estimate
WuXi Biologics (Cayman) Inc

For the last 8 years the compound annual growth rate for WuXi Biologics (Cayman) Inc's operating income is 46%. The projected CAGR for the next 3 years is 19%.

46%
Past Growth
19%
Estimated Growth
Estimates Accuracy
2%
Average Beat

Net Income
Forecast

Net Income Estimate
WuXi Biologics (Cayman) Inc

For the last 8 years the compound annual growth rate for WuXi Biologics (Cayman) Inc's net income is 49%. The projected CAGR for the next 3 years is 22%.

49%
Past Growth
22%
Estimated Growth
Estimates Accuracy
-7%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is WuXi Biologics (Cayman) Inc's stock price target?
Price Target
29.03 HKD

According to Wall Street analysts, the average 1-year price target for WuXi Biologics (Cayman) Inc is 29.03 HKD with a low forecast of 10.1 HKD and a high forecast of 47.25 HKD.

What is WuXi Biologics (Cayman) Inc's Revenue forecast?
Projected CAGR
15%

For the last 8 years the compound annual growth rate for WuXi Biologics (Cayman) Inc's revenue is 44%. The projected CAGR for the next 3 years is 15%.

What is WuXi Biologics (Cayman) Inc's Operating Income forecast?
Projected CAGR
19%

For the last 8 years the compound annual growth rate for WuXi Biologics (Cayman) Inc's operating income is 46%. The projected CAGR for the next 3 years is 19%.

What is WuXi Biologics (Cayman) Inc's Net Income forecast?
Projected CAGR
22%

For the last 8 years the compound annual growth rate for WuXi Biologics (Cayman) Inc's net income is 49%. The projected CAGR for the next 3 years is 22%.

Back to Top